CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism
Natural Alternatives International (NAI) and CarnoSyn® Brands will showcase TriBsyn™, a patent-pending formula, at the 46th ESPEN Congress on Clinical Nutrition & Metabolism in Milan, Italy from September 7-10, 2024. TriBsyn™ utilizes proprietary technology to increase beta-alanine bioavailability and absorption while eliminating paresthesia associated with high doses of beta-alanine.
The team will be at stand #16 to discuss the latest clinical evidence of TriBsyn™, which offers opportunities for various consumer groups, including older adults and vegans. Aaron Starr, VP of CarnoSyn® Brands, highlighted the product's potential in addressing the growing demand for healthy aging and wellness solutions. The team will also attend the 20th European Geriatric Medicine Society Congress in Valencia, Spain on September 18-20.
Natural Alternatives International (NAI) e CarnoSyn® Brands presenteranno TriBsyn™, una formula in fase di brevetto, al 46° Congresso ESPEN sulla Nutrizione Clinica e il Metabolismo a Milano, Italia, dal 7 al 10 settembre 2024. TriBsyn™ utilizza una tecnologia proprietaria per aumentare la biodisponibilità e l'assorbimento della beta-alanina eliminando la parestesia associata ad alte dosi di beta-alanina.
Il team sarà allo stand n. 16 per discutere le ultime evidenze cliniche di TriBsyn™, che offre opportunità per vari gruppi di consumatori, inclusi gli anziani e i vegani. Aaron Starr, VP di CarnoSyn® Brands, ha sottolineato il potenziale del prodotto nel rispondere alla crescente domanda di soluzioni per un invecchiamento sano e il benessere. Il team parteciperà anche al 20° Congresso della Società Europea di Medicina Geriatrica a Valencia, Spagna, dal 18 al 20 settembre.
Natural Alternatives International (NAI) y CarnoSyn® Brands presentarán TriBsyn™, una fórmula pendiente de patente, en el 46º Congreso ESPEN de Nutrición Clínica y Metabolismo en Milán, Italia, del 7 al 10 de septiembre de 2024. TriBsyn™ utiliza una tecnología propietaria para aumentar la biodisponibilidad y la absorción de beta-alanina eliminando la parestesia asociada con altas dosis de beta-alanina.
El equipo estará en el stand n. 16 para discutir las últimas evidencias clínicas de TriBsyn™, que ofrece oportunidades para varios grupos de consumidores, incluidos los adultos mayores y los veganos. Aaron Starr, VP de CarnoSyn® Brands, destacó el potencial del producto para abordar la creciente demanda de soluciones para un envejecimiento saludable y bienestar. El equipo también asistirá al 20º Congreso de la Sociedad Europea de Medicina Geriátrica en Valencia, España, del 18 al 20 de septiembre.
내추럴 얼터너티브스 인터내셔널 (NAI)과 카르노신® 브랜드는 2024년 9월 7일부터 10일까지 이탈리아 밀라노에서 열리는 제46회 ESPEN 임상 영양 및 대사학 Congress에서 특허 출원 중인 TriBsyn™을 선보일 것입니다. TriBsyn™은 독점 기술을 활용하여 베타-알라닌의 생체 이용률과 흡수율을 증가시키고 고용량 베타-알라닌과 관련된 감각 이상을 제거합니다.
팀은 16번 부스에서 TriBsyn™의 최신 임상 증거에 대해 논의하며, 노인과 비건을 포함하여 다양한 소비자 그룹을 위한 기회를 제공할 것입니다. 카르노신® 브랜드의 VP인 아론 스타르는 제품이 건강한 노화 및 웰빙 솔루션에 대한 증가하는 수요를 해결하는 데 잠재력이 있다고 강조했습니다. 팀은 또한 9월 18일부터 20일 사이에 스페인 발렌시아에서 열리는 제20회 유럽 노인 의학학회에 참석할 예정입니다.
Natural Alternatives International (NAI) et CarnoSyn® Brands présenteront TriBsyn™, une formule en instance de brevet, lors du 46ème Congrès ESPEN sur la Nutrition Clinique et le Métabolisme à Milan, Italie, du 7 au 10 septembre 2024. TriBsyn™ utilise une technologie propriétaire pour augmenter la biodisponibilité et l'absorption de la bêta-alanine tout en éliminant la paresthésie associée aux fortes doses de bêta-alanine.
L'équipe sera au stand n° 16 pour discuter des dernières preuves cliniques de TriBsyn™, qui offre des opportunités pour divers groupes de consommateurs, y compris les personnes âgées et les véganes. Aaron Starr, VP de CarnoSyn® Brands, a souligné le potentiel du produit pour répondre à la demande croissante de solutions pour un vieillissement sain et le bien-être. L'équipe assistera également au 20ème Congrès de la Société Européenne de Médecine Gériatrique à Valence, Espagne, du 18 au 20 septembre.
Natural Alternatives International (NAI) und CarnoSyn® Brands werden TriBsyn™, eine patentanhängige Formel, vom 7. bis 10. September 2024 auf dem 46. ESPEN-Kongress für Klinische Ernährung und Stoffwechsel in Mailand, Italien, präsentieren. TriBsyn™ nutzt proprietäre Technologie, um die Bioverfügbarkeit und Absorption von Beta-Alanin zu erhöhen und gleichzeitig die mit hohen Dosen von Beta-Alanin verbundene Paresthesie zu beseitigen.
Das Team wird am Stand Nr. 16 sein, um die neuesten klinischen Beweise für TriBsyn™ zu diskutieren, die Möglichkeiten für verschiedene Verbrauchergruppen, einschließlich älterer Erwachsener und Veganer, bietet. Aaron Starr, VP von CarnoSyn® Brands, hob das Potenzial des Produkts hervor, die wachsende Nachfrage nach gesunden Alternativen für das Altern und Wellness-Lösungen zu adressieren. Das Team wird auch am 20. Kongress der Europäischen Geriatrischen Medizinischen Gesellschaft in Valencia, Spanien, vom 18. bis 20. September teilnehmen.
- Introduction of TriBsyn™, a new patent-pending formula with increased beta-alanine bioavailability
- Expansion into untapped consumer markets, including older adults and vegans
- Potential applications in dietary supplements, fortified foods, and medical foods
- None.
CARLSBAD, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) and CarnoSyn® Brands will exhibit at the 46th ESPEN Congress on Clinical Nutrition & Metabolism in Milan, Italy on September 7-10, 2024. ESPEN 2024 offers a unique platform for companies to present and educate on innovative science in clinical nutrition and metabolism, fostering collaboration with physicians, dietitians, pharmacists, nutritionists, scientists, and nurses.
The NAI and CarnoSyn® Brands team will be available at stand #16 to discuss the latest clinical evidence of TriBsyn™, a patent-pending formula that utilizes proprietary technology to increase beta-alanine bioavailability and absorption, while effectively eliminating the common paresthesia sensation associated with efficacious dosages of beta-alanine. TriBsyn™ provides new opportunity to reach untapped consumers from older adults to vegans and anyone focused on wellness. Congress attendees are invited to visit the stand to learn more about this new product innovation.
Aaron Starr, Vice President, CarnoSyn® Brands stated, “We are excited to exhibit TriBsyn™ at this year’s ESPEN Congress on Clinical Nutrition and Metabolism and to share details behind the clinically proven formula. There is an evolving need and growing demand for healthy aging and wellness solutions, and this proprietary carnosine booster is a game changer for dietary supplement categories, as well as for fortified and medical foods, seeking benefit focus on muscle vitality, cognitive performance, and anti-aging support.”
Following ESPEN, the team will attend the 20th European Geriatric Medicine Society (EuGMS) Congress in Valencia, Spain on September 18-20.
Find out more about TriBsyn™ by visiting ESPEN stand #16 or www.tribsyn.com.
About CarnoSyn® Brands:
CarnoSyn® Brands feature three clinically studied, patented ingredients available exclusively from Natural Alternatives International, Inc.: CarnoSyn® instant release beta-alanine powder, SR CarnoSyn® sustained release beta-alanine tablets, and TriBsyn™ powder. In 2019, CarnoSyn® beta-alanine successfully obtained NDI status from the FDA and received Self-Affirmed GRAS (Generally Recognized as Safe) status. SR CarnoSyn®, an advanced delivery form of CarnoSyn®, received GRAS affirmation in 2017. The new “paresthesia-free” TriBsyn™ powder allows NAI to broaden their product offerings within the dietary supplement category, including medical and other fortified food products. To learn more about SR CarnoSyn® in active nutrition and wellness, visit www.srcarnosyn.com. For more information about the latest innovation, TriBsyn™, visit www.tribsyn.com.
About NAI:
NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. NAI’s comprehensive partnership approach offers a wide range of innovative nutritional products and services to clients including scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance. For more information about NAI, please visit www.nai-online.com.
Contact:
Renee Michaelson
Director of Global Marketing
NAI/CarnoSyn® Brands
(760) 736-7700
info@nai-online.com
FAQ
What is TriBsyn™ and how does it differ from regular beta-alanine supplements?
Where and when will Natural Alternatives International (NAII) showcase TriBsyn™?
What are the potential applications for TriBsyn™ according to Natural Alternatives International (NAII)?
Will Natural Alternatives International (NAII) attend any other events to promote TriBsyn™?
